ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Trial court denied Company’s motion for a new trial and judgment as a matter of law for unjust enrichment ANI intends to appeal rulings to the Delaware Supreme Court and continue to seek to recover the value of the assets it sold to CG Oncology in 2010